BlackRock Fund Advisors’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $200K | Sell |
46,366
-295,269
| -86% | -$1.27M | ﹤0.01% | 3426 |
|
|
2016
Q3 | $3.36M | Buy |
341,635
+96,278
| +39% | +$947K | ﹤0.01% | 3032 |
|
|
2016
Q2 | $1.39M | Sell |
245,357
-364,736
| -60% | -$2.06M | ﹤0.01% | 3235 |
|
|
2016
Q1 | $4.65M | Sell |
610,093
-2,747
| -0.4% | -$20.9K | ﹤0.01% | 2781 |
|
|
2015
Q4 | $8.16M | Buy |
612,840
+202,331
| +49% | +$2.7M | ﹤0.01% | 2564 |
|
|
2015
Q3 | $6.75M | Sell |
410,509
-27,013
| -6% | -$444K | ﹤0.01% | 2606 |
|
|
2015
Q2 | $9.82M | Buy |
437,522
+2,093
| +0.5% | +$47K | ﹤0.01% | 2510 |
|
|
2015
Q1 | $4.26M | Buy |
435,429
+61,388
| +16% | +$600K | ﹤0.01% | 2920 |
|
|
2014
Q4 | $4.26M | Buy |
374,041
+52,120
| +16% | +$594K | ﹤0.01% | 2963 |
|
|
2014
Q3 | $3.71M | Buy |
321,921
+26,763
| +9% | +$308K | ﹤0.01% | 2917 |
|
|
2014
Q2 | $5.74M | Buy |
295,158
+260,270
| +746% | +$5.06M | ﹤0.01% | 2760 |
|
|
2014
Q1 | $626K | Buy |
34,888
+6,574
| +23% | +$118K | ﹤0.01% | 3231 |
|
|
2013
Q4 | $299K | Sell |
28,314
-115,222
| -80% | -$1.22M | ﹤0.01% | 3320 |
|
|
2013
Q3 | $1.77M | Buy |
143,536
+34,223
| +31% | +$423K | ﹤0.01% | 3139 |
|
|
2013
Q2 | $1.03M | Buy |
+109,313
| New | +$1.03M | ﹤0.01% | 3154 |
|